Pablo G. B.
- Country
- Spain
- Department
- Cardiology
Research Overview
- Effect of Muvalaplin on Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: A Phase 3 Randomized Trial
- Inclisiran for Prevention of Major Adverse Cardiovascular Events in High-Risk Primary Prevention Patients with Atherosclerotic Cardiovascular Disease
- Evaluation of Obicetrapib on Major Adverse Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients on Maximal Lipid-Modifying Therapy
Data & Insights
Has run more than one trial at 478 of 950 partner sites.
Specializations
Metabolic Disorders
This investigator specializes in the treatment and research of rare and severe metabolic conditions, with particular focus on lipid disorders and their management.
- Familial Chylomicronemia Syndrome (FCS)
- Severe Hypertriglyceridemia
Their work involves exploring therapeutic interventions for patients with severe lipid metabolism disorders that can lead to serious health complications.
Therapeutic Innovation
The investigator's research encompasses novel therapeutic approaches in lipid-lowering treatments, including the evaluation of innovative compounds.
- Advanced lipid-modifying therapies
- Novel therapeutic compounds
Their work focuses on investigating treatments that may provide new options for patients with severe metabolic disorders affecting triglyceride levels.
Clinical Management
The investigator concentrates on developing approaches for managing patients with severe lipid disorders, particularly those affecting triglyceride metabolism.
- Long-term treatment strategies
- Patient monitoring protocols
Their expertise extends to evaluating treatment efficacy and safety in patients with severe metabolic conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.